Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-21-022775
Filing Date
2021-09-28
Accepted
2021-09-28 16:24:53
Documents
2
Period of Report
2021-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1489
2 gnpxpoakumarconfervaczy.txt EX-24 4896
  Complete submission text file 0001437749-21-022775.txt   7748
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Issuer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3300 BEE CAVE ROAD #650-227 AUSTIN TX 78746
Business Address
Kumar Hermant (Reporting) CIK: 0001884546 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38244 | Film No.: 211287186